References
- KumarGPKhanumFNeuroprotective potential of phytochemicalsPharmacogn Rev2012612819023055633
- The Huntington’s Disease Collaboration GroupA novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomesCell19937269719838458085
- BanoDZanettiFMendeYNeurodegenerative processes in Huntington’s diseaseCell Death Dis20112e22822071633
- DaviesSWTurmaineMCozensBAFormation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutationCell19979035375489267033
- SchillingGBecherMWSharpAHIntranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtinHum Mol Genet1999833974079949199
- BealMFAging, energy, and oxidative stress in neurodegenerative diseasesAnn Neurol19953833573667668820
- JenkinsBGKoroshetzWJBealMFEvidence for impairment of energy metabolism in vivo in Huntington’s disease using localized 1H NMR spectroscopyNeurology19934312268926958255479
- Munoz-SanjuanIBatesGPThe importance of integrating basic and clinical research toward the development of new therapies for Huntington diseaseJ Clin Invest2011121247648321285520
- WangSELinCLHsuCHTreatment with a herbal formula B401 enhances neuroprotection and angiogenesis in the R6/2 mouse model of Huntington’s diseaseDrug Des Dev Ther20159887900
- BealMFMitochondria, free radicals and neurodegenerationCurr Opin Neurobiol1996656616668937831
- Portera-CailliauCHedreenJCPriceDLEvidence for apoptotic cell death in Huntington disease and excitotoxic animal modelsJ Neurosci19955Pt 2377537877751945
- MangiariniLSathasivamKSellerMExon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic miceCell19968734935068898202
- ChienCTFanSCLinSCGlucagon-like peptide-1 receptor agonist activation ameliorates venous thrombosis-induced arteriovenous fistula failure in chronic kidney diseaseThromb Haemost201411251051106425030617
- GutekunstCALiSHYiHNuclear and neuropil aggregates in Huntington’s disease: relationship to neuropathologyJ Neurosci19991972522253410087066
- ChongZZLiFMaieseKOxidative stress in the brain: novel cellular targets that govern survival during neurodegenerative diseaseProg Neurobiol200575320724615882775
- HickeyMAChesseletMFApoptosis in Huntington’s diseaseProg Neuropsychopharmacol Biol Psychiatry200327225526512657365
- ChenXCZhuYGZhuLAGinsenoside Rg1 attenuates dopamine-induced apoptosis in PC12 cells by suppressing oxidative stressEur J Pharmacol200347311712877931
- YuSLiSYangHA novel liquid chromatography/tandem mass spectrometry based depletion method for measuring red blood cell partitioning of pharmaceutical compounds in drug discoveryRapid Commun Mass Spectrom200519225025415609367
- FerranteRJGutekunstCAPersichettiFHeterogeneous topographic and cellular distribution of huntingtin expression in the normal human neostriatumJ Neurosci1997179305230639096140
- HalliwellBRole of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatmentDrugs Aging200118968571611599635
- WyttenbachASauvageotOCarmichaelJHeat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtinHum Mol Genet20021191137115111978772
- RaoRVBredesenDEMisfolded proteins, endoplasmic reticulum stress and neurodegenerationCurr Opin Cell Biol200416665366215530777
- TattonWGOlanowCWApoptosis in neurodegenerative diseases: the role of mitochondriaBiochim Biophys Acta19991410219521310076027